Iaso Therapeutics Receives Grant from the National Science Foundation for Next-Generation Vaccine Research

2022-03-14T11:27:00-04:00

The nearly $1 million grant will fund vaccine delivery research targeting infectious diseases and cancer EAST LANSING, Mich., March 14, 2022 -- Iaso Therapeutics, a research program focused on the [...]

Iaso Therapeutics Receives Grant from the National Science Foundation for Next-Generation Vaccine Research2022-03-14T11:27:00-04:00

Iaso Therapeutics Awarded Competitive Grant from the National Institute of Allergy and Infectious Diseases

2022-02-11T13:57:41-05:00

Small Business Innovation Research Program Provides Seed Funding for R&D East Lansing, MI, 07/15/2021 – Iaso Therapeutics, INC. has been awarded a National Institute of Allergy and Infectious Diseases (NIAID) [...]

Iaso Therapeutics Awarded Competitive Grant from the National Institute of Allergy and Infectious Diseases2022-02-11T13:57:41-05:00

Iaso Therapeutics Invited to TRECS Workshop

2021-09-05T13:54:07-04:00

East Lansing, MI – Iaso Therapeutics (Iaso) has received a selective invitation to participate in the National Cancer Institute (NCI) Translational Resources to Expedite Commercialization Success Workshop (TRECS WORKSHOP). Iaso [...]

Iaso Therapeutics Invited to TRECS Workshop2021-09-05T13:54:07-04:00
Go to Top